微生物组特征及其在紫外线炎中的作用:病变发生,诊断和治疗前景
Kajal Agrawal1, Ashley Shuen Ying Hong2, Carlos Cifuentes-González3
1Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Progress in retinal and eye research
|October 12, 2025
概括
肠道微生物群通过改变免疫反应和屏障功能来影响非传染性尿膜炎. 微生物组信息化策略为这种复杂的眼睛疾病提供了新的治疗途径.
科学领域:
- 免疫学 免疫学 免疫学
- 眼科医生 眼科 眼科
- 微生物组研究 微生物组研究
背景情况:
- 非传染性脑膜炎涉及遗传,免疫和环境因素.
- 粘膜微生物组 (肠道,口腔,眼睛) 关键调节免疫反应.
- 一个肠眼轴将肠道失生症与系统性免疫激活和眼部炎症联系起来.
研究的目的:
- 审查微生物组在非传染性紫外线炎病原发生中的作用.
- 探索将微生物组变化与眼部炎症联系起来的机制.
- 识别微生物组信息的诊断和治疗机会.
主要方法:
- 综合当前研究和实验发现的文献综述.
- 分析从元基因组学,代谢学和小鼠模型的见解.
- 描述四个关键机制:免疫失衡,抗原仿真,屏障破坏和细菌转移.
主要成果:
- 微生物失生症通过改变肠道屏障功能和T细胞平衡作用,导致紫外线炎.
- 特定的种类 (Prevotella,Faecalibacterium) 和代谢物 (SCFA) 影响眼睛的炎症.
- 基因-微生物组-免疫相互作用 (例如,HLA等位基因) 在紫外线炎中至关重要.
结论:
- 微生物群通过多种机制在非传染性紫外线炎的发病过程中发挥着重要作用.
- 益生菌和饮食调节等微生物组知情策略显示出治疗前景.
- 需要精准医学方法,整合微生物组科学,以有效地管理紫外线炎.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
637
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
637
Microorganisms in Medicine and Therapeutics
960
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
960
Inflammatory Bowel Disease IV: Pharmacological Management
517
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
517
Irritable Bowel Syndrome I: Introduction
919
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
919
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
536
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
536


